NLS Pharmaceutics Appoints Chad C. Hellmann as Chief Financial Officer

Go back to NLS Pharmaceutics Appoints Chad C. Hellmann as Chief Financial Officer
(NASDAQ: NLSP) Delayed: 0.76 --0 (-0%)
Previous Close $0.76    52 Week High
Open $0.76    52 Week Low
Day High $0.76    P/E N/A 
Day Low $0.76    EPS
Volume 100       

(NASDAQ: NLSPW) Delayed: 0.02 --0 (-0%)
Previous Close $0.02    52 Week High
Open $0.02    52 Week Low
Day High $0.02    P/E N/A 
Day Low $0.02    EPS
Volume 100